Table 1.
Clinical characteristics of CAD patients and healthy subjects.
| Parameter | N (n = 28) | SA (n = 40) | ACS (n = 53) |
|---|---|---|---|
| Anthropometric data | |||
| Age (years) | 41 ± 9.5 | 61 ± 8.0*** | 63 ± 9.0*** |
| Gender Male (n, %) | 12 (43%) | 26 (65%)*** | 31 (58%)*** |
| BMI (kg/m2) | 25 ± 0.8 | 30 ± 0.9*** | 28 ± 0.7** |
| Diagnosis | |||
| Obese (BMI > 30 kg/m2) (n, %) | 4 (14%) | 17 (42%) | 23 (42%) |
| Diabetes mellitus (n, %) | 0 (0%) | 15 (37%) | 19 (35%) |
| Hypertension (n, %) | 0 (0%) | 32 (80%) | 38 (71%) |
| Treatment | |||
| Statin therapy (n, %) | 0 (0%) | 40 (100%) | 53 (100%) |
| Aspirin (n, %) | 0 (0%) | 30 (75%) | 36 (67%) |
| Anti-platelets therapy (n, %) | 0 (0%) | 20 (50%) | 30 (56%) |
| Anti-diabetic therapy (n, %) | 0 (0%) | 15 (37%) | 19 (35%) |
| ACE-Inhibitor (n, %) | 0 (0%) | 29 (72%) | 38 (71%) |
N - healthy subjects, SA - stable angina patients and ACS - acute coronary syndrome patients; n - number of subjects, BMI - body mass index.
Data for age are expressed as means ± standard deviation (SD). The BMI data are expressed as means ± standard error of the mean (SEM) and analyzed with two-tailed Oneway ANOVA with Least Significant Difference (LSD) Post-hoc test. Chi-squared (χ2) analysis was used to evaluate the differences between two groups of binary logistic data (gender, obesity, diabetes, hypertension, medication). **p < 0.01, ***p < 0.001 vs. N.